Vivos (RDGL) Change in Inventory (2010 - 2025)

Vivos' (RDGL) quarterly Change in Inventory came in at -$5477.0 in Q4 2025, down 2312.78% quarter-over-quarter from -$227.0 in Q3 2025.

Vivos (RDGL) Change in Inventory (2010 - 2025) Analysis & Trends

Vivos has disclosed Change in Inventory across 5 years of filings, most recently posting -$5477.0 for Q4 2025.

  • Change in Inventory for Q4 2025 came in at -$5477.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $57257.0 (changed N/A YoY), and the FY2025 annual result was $57257.0, changed N/A from the prior year.
  • Change in Inventory came in at -$5477.0 for Q4 2025 at Vivos, down from -$227.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $41763.0 in Q2 2025 to a low of -$5477.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 420.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 127.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 131.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 177.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 1.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -264.59 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 65.20 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 171.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -38.50 Mn
10 Vivos - - -3,105.00 -5,477.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -5,477.00
Dec 31, 2025 -5,477.00
Sep 30, 2025 -227.00
Sep 30, 2025 -227.00
Jun 30, 2025 41,763.00
Jun 30, 2025 41,763.00
Mar 31, 2025 21,198.00
Mar 31, 2025 21,198.00
Dec 31, 2013 -8,750.00
Dec 31, 2013 -8,750.00
Jun 30, 2013 8,750.00
Jun 30, 2013 8,750.00
Mar 31, 2013 -4,375.00
Mar 31, 2013 -4,375.00
Dec 31, 2012 -475.00
Dec 31, 2012 -475.00
Sep 30, 2012 4,850.00
Sep 30, 2012 4,850.00
Jun 30, 2012 -2,025.00
Jun 30, 2012 -2,025.00